|1||NCT02573493||Recruiting||Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)||
||Other / Industry||
||110||All||18 Years and older (Adult, Older Adult)||NCT02573493||201510013||APA||April 13, 2016||May 31, 2019||October 31, 2029||October 9, 2015||January 29, 2019||
|2||NCT01874171||Active, not recruiting||Determination of Cetuximab Versus Cisplatin Early and Late Toxicity Events in HPV+ OPSCC||
||334||All||18 Years and older (Adult, Older Adult)||NCT01874171||RMRCT0034
|De-ESCALaTE||November 15, 2012||February 2019||February 2019||June 10, 2013||May 8, 2017||
† Study has passed its completion date and status has not been verified in more than two years.